| Adenosine A1 receptor |
Ki |
= |
0.59 |
nM |
Inhibition of binding of [3H]N6-cyclohexyladenosine to adenosine A1 receptor of rat whole brain membranes. |
CHEMBL1124694 |
| Adenosine A2 receptor |
Ki |
= |
460.0 |
nM |
Inhibition of binding of [3H]NECA to adenosine A2 receptor of rat striatal membranes. |
CHEMBL1124694 |
| Adenosine receptors; A1 & A2 |
Ratio |
= |
780.0 |
|
Selectivity ratio for A1 receptor to that of A2 receptor in vitro in rat tissues |
CHEMBL1124694 |
| Adenosine A1 receptor |
Ki high |
= |
0.8 |
nM |
Binding affinity against adenosine A1 receptor using [3H]CCPA in guinea pig DDT membrane |
CHEMBL1137935 |
| Adenosine A1 receptor |
Ki low |
= |
19.5 |
nM |
Binding affinity against adenosine A1 receptor using [3H]CPX in guinea pig DDT membrane; 19.5+/-12.0 |
CHEMBL1137935 |
| Adenosine A1 receptor |
CPA |
= |
100.0 |
% |
Binding affinity against GTPgammaS receptor using [35S]GTP-gamma-S, radioligand in guinea pig. |
CHEMBL1137935 |
| Phosphoglycerate kinase |
IC50 |
= |
3900000.0 |
nM |
evaluated for the inhibition of Trypanosoma brucei Phosphoglycerate kinase (PGK) |
CHEMBL1133593 |
| Rattus norvegicus |
IC50 |
= |
10.0 |
nM |
In vitro inhibition of synaptic potential in the hippocampal formation (synaptic responses (fEPSPs) recorded in the CAI region of in vivo hippocampal slices in rat brain) |
CHEMBL1125345 |
| Adenosine A1 receptor |
Ki |
= |
0.59 |
nM |
Inhibition of [3H]PIA binding to rat cortical adenosine A1 receptor |
CHEMBL1125345 |
| Unchecked |
EC50 |
= |
2.8 |
nM |
Potency to inhibit A1-adenosine receptor mediated cAMP accumulation in DDT1 MF-2 cells |
CHEMBL1131274 |
| Adenosine A1 receptor |
Ki |
= |
0.32 |
nM |
Inhibition of [3H]-CHA binding to rat brain membrane Adenosine A1 receptor |
CHEMBL1125020 |
| Adenosine A2 receptor |
Ki |
= |
1.1 |
nM |
Binding of Adenosine A2 receptor in whole rat brain membrane using [3H]CHA as a Radioligand |
CHEMBL1125020 |
| Unchecked |
IC50 |
= |
19.2 |
nM |
Inhibition of Adenylate Cyclase in Rat adipocytes |
CHEMBL1125020 |
| Adenosine A1 receptor |
Ki |
= |
0.59 |
nM |
Binding affinity at adenosine A1 receptor from rat brain membranes by [3H]N6-cyclohexyladenosine displacement. |
CHEMBL1124142 |
| Adenosine A2 receptor |
Ki |
= |
460.0 |
nM |
Binding affinity at adenosine A2 receptor from rat striatal membranes by [3H]NECA displacement. |
CHEMBL1124142 |
| Adenosine receptors; A1 & A2 |
Ratio |
= |
780.0 |
|
Ratio of binding affinity against A2 and A1 receptors |
CHEMBL1124142 |
| Adenosine A1 receptor |
IC50 |
= |
720.0 |
nM |
Binding affinity towards adenosine A1 receptor rat brain membranes with 1 M NaCl by inhibition of [125-I]-labeled aminobenzyl adenosine binding |
CHEMBL1124076 |
| Adenosine A1 receptor |
IC50 |
= |
0.35 |
nM |
Binding affinity to adenosine A1 receptor of rat brain membranes without NaCl by inhibition of [125-I]-labeled aminobenzyl adenosine binding |
CHEMBL1124076 |
| Adenosine A1 receptor |
Ki |
= |
5.9 |
nM |
Displacement of [3H]DPCPX (without GTP) from Adenosine A1 receptor of rat cortical membrane |
CHEMBL1129060 |
| Adenosine A1 receptor |
Ki |
= |
35.0 |
nM |
Displacement of [3H]DPCPX (with GTP) from Adenosine A1 receptor of rat cortical membrane |
CHEMBL1129060 |
| Adenosine A1 receptor |
GTP shift |
= |
6.0 |
|
Relative affinities for rat Adenosine A1 receptor in the presence and absence of GTP |
CHEMBL1129060 |
| Adenosine A2 receptor |
Ki |
= |
580.0 |
nM |
Displacement of [3H]-CGS- 21680 from Adenosine A2 receptor of rat striatal membranes |
CHEMBL1129060 |
| Rattus norvegicus |
Heart rate |
= |
345.0 |
beats min-1 |
Effect on heart rate was measured after intravenous administration (4.8 mg/kg) in rat |
CHEMBL1129060 |
| Rattus norvegicus |
Reduction |
= |
54.0 |
% |
Maximum reduction heart rate of ratat a dose of 0.20 mg/kg |
CHEMBL1129060 |
| Rattus norvegicus |
MAP |
= |
109.0 |
mmHg |
Mean arterial pressure was recorded of conscious, normo tensive and unrestrained rats that received an intravenous infusion of drugs at a dose of 0.20 mg/kg |
CHEMBL1129060 |
| Rattus norvegicus |
Reduction |
= |
61.0 |
% |
Maximum reduction heart rate of rat at a dose of 0.20 mg/kg |
CHEMBL1129060 |
| Adenosine A1 receptor |
Ki |
= |
0.59 |
nM |
Binding affinity towards adenosine A1 receptor on rat whole brain membrane using [3H]N6-cyclohexyladenosine |
CHEMBL1124304 |
| Adenosine A2 receptor |
Ki |
= |
460.0 |
nM |
Binding affinity towards adenosine A2 receptor on rat striatal membrane using [3H]NECA as radioligand |
CHEMBL1124304 |
| Adenosine A1 receptor |
EC25 |
= |
3.0 |
nM |
Reduction of heart rate (A1 response) in isolated rat heart preparation |
CHEMBL1124304 |
| Adenosine A2 receptor |
EC25 |
> |
100.0 |
nM |
Enhancement of coronary flow (A2 response) in isolated rat heart preparation |
CHEMBL1124304 |
| Adenosine receptors; A1 & A2 |
Ratio |
= |
780.0 |
|
Ratio of Ki at adenosine A2 and A1 receptors |
CHEMBL1124304 |
| Alpha-1a adrenergic receptor |
MPR |
= |
1.8 |
|
Molar potency ratio was evaluated |
CHEMBL1123137 |
| ADMET |
k' |
= |
1.25 |
|
HPLC capacity factor (k') |
CHEMBL1123137 |
| Adenosine A1 receptor |
Ki |
= |
1.2 |
nM |
Tested for inhibition of adenosine A1 receptor binding to rat brain |
CHEMBL1126992 |
| Adenosine A2 receptor |
Ki |
= |
321.0 |
nM |
Tested for inhibition of adenosine A2 receptor binding to rat brain |
CHEMBL1126992 |
| No relevant target |
LogP |
= |
0.72 |
|
Partition coefficient (logP) |
CHEMBL1126992 |
| Cavia porcellus |
IC50 |
= |
0.6 |
nM |
Tested for agonistic potency to inhibit stimulated cAMP accumulation in isolated guinea pig heart |
CHEMBL1126992 |
| Cavia porcellus |
IC50 |
= |
420.0 |
nM |
Tested for agonistic potency to inhibit contractile force in isolated guinea pig atria |
CHEMBL1126992 |
| Adenosine A1 receptor |
Ki |
= |
1.2 |
nM |
Displacement of [3H]R-PIA from adenosine A1 receptor of Wistar rat forebrain |
CHEMBL1132368 |
| Adenosine A2a receptor |
Ki |
= |
321.0 |
nM |
Displacement of [3H]-CGS- 21680 from adenosine A2A receptor of rat striatal tissue |
CHEMBL1132368 |
| Unchecked |
IC50 |
= |
0.5 |
nM |
In vitro inhibition of isoprenaline-stimulated cAMP accumulation in DDT1-MF2 cells (measured by adenosine A1 functional assay) |
CHEMBL1132368 |
| Cavia porcellus |
EC50 |
= |
420.0 |
nM |
Negative inotropy effect in isolated guinea pig atria. |
CHEMBL1132368 |
| Mus musculus |
ED50 |
= |
0.07 |
mg.kg-1 |
In vivo inhibition of spontaneous locomotor activity of mouse by the compound 30 min after intraperitoneal administration. |
CHEMBL1132368 |
| Mus musculus |
ED50 |
= |
0.17 |
mg.kg-1 |
In vivo inhibition of DMCM-induced seizures in mouse by the compound 30 min after intraperitoneal administration |
CHEMBL1132368 |
| Gerbillinae |
Reduction |
= |
75.0 |
|
Reduction in hippocampal cell death by compound administered 30 min after a period of severe forebrain ischemia in the Mongolian gerbil at 0.3 mg/kg |
CHEMBL1132368 |
| Rattus norvegicus |
Reduction |
= |
62.0 |
% |
Percent reduction in blood pressure in an anesthetized rat 5 min after intravenous administration of 0.1 mg/kg of compound |
CHEMBL1132368 |
| Adenosine A1 receptor |
Ki |
= |
5.9 |
nM |
Binding affinity against adenosine A1 receptor using [3H]DPCPX in rat cortical membranes in the absence of GTP |
CHEMBL1131197 |
| Adenosine A1 receptor |
Ki |
= |
35.2 |
nM |
Binding affinity against adenosine A1 receptor using [3H]DPCPX in rat cortical membranes in the presence of GTP. |
CHEMBL1131197 |
| Adenosine A2a receptor |
Ki |
= |
580.0 |
nM |
Binding affinity against Adenosine A2A receptor using [3H]-CGS- 21680 as the radioligand in rat striatal membranes |
CHEMBL1131197 |
| Adenosine A1 receptor |
EC50 |
= |
14.3 |
nM |
Effective concentration for [35S]GTP-gamma-S, binding to adenosine A1 receptor in rat brain membranes |
CHEMBL1131197 |
| Adenosine A1 receptor |
Activity |
= |
100.0 |
% |
Intrinsic activity for maximum stimulation of [35S]GTP-gamma-S, binding to adenosine A1 receptor in rat brain membranes |
CHEMBL1131197 |
| Adenosine A1 receptor |
Ki |
= |
0.8 |
nM |
Binding affinity against high affinity component of adenosine A1 receptors from rat brain membranes using [3H]DPCPX |
CHEMBL1126089 |
| Adenosine A1 receptor |
Ki |
= |
130.0 |
nM |
Binding affinity against low affinity component of adenosine A1 receptors from rat brain membranes using [3H]-DPCPX |
CHEMBL1126089 |
| Adenosine A1 receptor |
Ki |
= |
0.8 |
nM |
Binding affinity against adenosine A1 receptors from rat brain membranes using [3H]CCPA |
CHEMBL1126089 |
| Adenosine A2 receptor |
Ki |
= |
2000.0 |
nM |
Binding affinity against adenosine A2 receptor from rat striatal membranes with 50 nM CPA using [3H]-NECA |
CHEMBL1126089 |
| Adenosine A2 receptor |
Ki |
= |
2400.0 |
nM |
Binding affinity against adenosine A2 receptor from human platelet membranes using [3H]NECA |
CHEMBL1126089 |
| Adenosine receptors; A1 & A2 |
A2 selectivity |
= |
0.0004 |
|
Selectivity as A1 adenosine receptors(high affinity) using [3H]-DPCPX compared to A2 adenosine receptors using [3H]NECA in rat striatal membranes |
CHEMBL1126089 |
| Adenosine receptors; A1 & A2 |
A2 selectivity |
= |
0.0004 |
|
Selectivity as A1 adenosine receptors(high affinity) using [3H]CCPA compared to A2 adenosine receptors using [3H]-NECA in rat striatal membranes |
CHEMBL1126089 |
| Adenosine A1 receptor |
Ki |
= |
5.9 |
nM |
Displacement of [3H]DPCPX from rat cortical membranes Adenosine A1 receptor |
CHEMBL1132635 |
| Adenosine A2a receptor |
Ki |
= |
580.0 |
nM |
Displacement of [3H]-CGS- 21980 from Adenosine A2A receptor of rat striatal membranes |
CHEMBL1132635 |
| Adenosine A3 receptor |
Ki |
= |
120.0 |
nM |
Binding affinity at human Adenosine A3 receptor expressed in HEK 293 cells by [125I]AB-MECA displacement. |
CHEMBL1132635 |
| Adenosine receptors; A1 & A3 |
Ratio |
= |
0.05 |
|
Ratio of displacement of A1 receptor to A3 receptor |
CHEMBL1132635 |
| Adenosine A1 receptor |
Ki |
= |
5.9 |
nM |
Binding affinity against adenosine A1 receptor using [3H]DPCPX in rat cortical membranes in the absence of GTP |
CHEMBL1131197 |
| Adenosine A1 receptor |
Ki |
= |
35.2 |
nM |
Binding affinity against adenosine A1 receptor using [3H]DPCPX in rat cortical membranes in the presence of GTP. |
CHEMBL1131197 |
| Adenosine A2a receptor |
Ki |
= |
580.0 |
nM |
Binding affinity against Adenosine A2A receptor using [3H]-CGS- 21680 as the radioligand in rat striatal membranes |
CHEMBL1131197 |
| Adenosine A1 receptor |
EC50 |
= |
14.3 |
nM |
Effective concentration for [35S]GTP-gamma-S, binding to adenosine A1 receptor in rat brain membranes |
CHEMBL1131197 |
| Adenosine A1 receptor |
Activity |
= |
100.0 |
% |
Intrinsic activity for maximum stimulation of [35S]GTP-gamma-S, binding to adenosine A1 receptor in rat brain membranes |
CHEMBL1131197 |
| Glyceraldehyde-3-phosphate dehydrogenase liver |
IC50 |
> |
5000000.0 |
nM |
Inhibitory activity measured for Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) in Leishmania. mexicana |
CHEMBL1131193 |
| Glyceraldehyde-3-phosphate dehydrogenase liver |
Inhibition |
= |
62.0 |
% |
Inhibitory activity was measured for Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) in Leishmania. mexicana at 10 mM |
CHEMBL1131193 |
| Adenosine A1 receptor |
EC50 |
= |
0.19 |
nM |
Compound was evaluated for the Adenosine A1 receptor agonist potency. |
CHEMBL1129007 |
| Unchecked |
Max inhibition |
= |
80.0 |
% |
Compound was evaluated for the maximal inhibition of (-)-isoproterenol stimulated cAMP accumulation in DDT-1 MF-2 cells |
CHEMBL1129007 |
| Adenosine A1 receptor |
Ki |
= |
5.07 |
nM |
Binding affinity for adenosine A1 receptor was assayed by displacement of [3H]DPCPX from rat cortical membranes. |
CHEMBL1133444 |
| Adenosine A2a receptor |
Ki |
= |
3370.0 |
nM |
Binding affinity for adenosine A2A receptor was determined by displacement of [3H]-DPCPX from rat striatal membranes. |
CHEMBL1133444 |
| Adenosine A1 receptor |
EC50 |
= |
13.3 |
nM |
Stimulation of [35S]GTP-gamma-S, binding to rat brain membranes by adenosine A1 receptor activation |
CHEMBL1133444 |
| Adenosine A1 receptor |
RIA |
= |
101.6 |
% |
Percent relative intrinsic activity compared to CCPA |
CHEMBL1133444 |
| Adenosine receptors; A1 & A2a |
Selectivity |
= |
665.0 |
|
Selectivity ratio of Ki of the adenosine A2a receptor and Ki of adenosine A1 receptor |
CHEMBL1133444 |
| Adenosine A1 receptor |
Ki |
= |
0.59 |
nM |
Tested for the binding affinity of A1 receptor by displacing the [3H]-PIA in rat brain membranes |
CHEMBL1127377 |
| Adenosine A2a receptor |
Ki |
= |
462.0 |
nM |
Tested for the binding affinity of A2a receptor by displacing the [3H]-CGS- 21680 in rat striatal membranes |
CHEMBL1127377 |
| Adenosine A3 receptor |
Ki |
= |
240.0 |
nM |
Tested for the binding affinity of A3 receptor by displacing N6-[[125I]-4-amino-3-iodobenzyl]-adenosine-5''-N-methyluronamide from membranes of CHO cells transfected with rat A3-cDNA |
CHEMBL1127377 |
| Adenosine receptors; A1 & A3 |
Ratio |
= |
0.0025 |
|
Ratio of Ki for A1 and A3 receptors |
CHEMBL1127377 |
| Adenosine receptor A2a and A3 |
Ratio |
= |
1.9 |
|
Ratio of Ki for A2a and A3 receptors |
CHEMBL1127377 |
| Adenosine A1 receptor |
Ki |
= |
1.5 |
nM |
Displacement of [3H]R-PIA from rat brain membrane Adenosine A1 receptor |
CHEMBL1133730 |
| Adenosine A2a receptor |
Ki |
= |
857.0 |
nM |
Displacement of specific [3H]-CGS- 21680 binding to adenosine A2A receptor in rat striatal membranes |
CHEMBL1133730 |
| Adenosine A2b receptor |
Ki |
= |
21200.0 |
nM |
Displacement of [3H]- ZM-241385 from human adenosine A2B receptor expressed in HEK cells |
CHEMBL1133730 |
| Adenosine A3 receptor |
Ki |
= |
274.0 |
nM |
Displacement of [125I]- AB-MECA from rat adenosine A3 receptor expressed in CHO cells |
CHEMBL1133730 |
| Adenosine A1 receptor |
EC50 |
= |
4.15 |
nM |
Stimulation of [35S]GTP-gamma-S, binding to human adenosine A1 receptor |
CHEMBL1133730 |
| Adenosine A1 receptor |
Max |
= |
100.0 |
% |
Maximum stimulation against human adenosine A1 receptor |
CHEMBL1133730 |
| Adenosine A1 receptor |
EC50 |
= |
20.3 |
nM |
Stimulation of [35S]GTP-gamma-S, binding to adenosine A1 receptor of rat cerebral cortical membrane |
CHEMBL1133730 |
| Adenosine A1 receptor |
Max |
= |
100.0 |
% |
Maximum stimulation against adenosine A1 receptor of rat cerebral cortical membrane |
CHEMBL1133730 |
| Adenosine A3 receptor |
EC50 |
= |
7980.0 |
nM |
Stimulation of [35S]GTP-gamma-S, against human adenosine A3 receptor |
CHEMBL1133730 |
| Adenosine A3 receptor |
Max |
= |
100.0 |
% |
Maximum stimulation against human adenosine A3 receptor |
CHEMBL1133730 |
| Adenosine receptors; A1 & A3 |
Ratio |
= |
0.0055 |
|
Relative binding affinity for Adenosine A1 and A3 receptors |
CHEMBL1133730 |
| Adenosine A1 receptor |
Ki |
= |
0.59 |
nM |
Binding affinity against adenosine A1 receptor using [3H]-CHA or [3H]PIA as radioligand |
CHEMBL1125572 |
| Adenosine A2 receptor |
Ratio |
= |
462.0 |
nM |
Binding affinity against adenosine A2 receptor using [3H]- NECA as radioligand |
CHEMBL1125572 |
| Adenosine receptors; A1 & A2 |
Ratio |
= |
780.0 |
|
Ratio of A2 to A1. |
CHEMBL1125572 |
| Adenosine A1 receptor |
Ki |
= |
0.3 |
nM |
Inhibitory activity at Adenosine A1 receptor by inhibition of [3H]CHA binding to bovine brain cortical membranes. |
CHEMBL1131221 |
| Adenosine A2a receptor |
Ki |
= |
385.0 |
nM |
Inhibitory activity at Adenosine A2A receptor by inhibition of [3H]-CGS- 21680 binding to bovine striatal membranes. |
CHEMBL1131221 |
| Adenosine A3 receptor |
Ki |
= |
26.0 |
nM |
Inhibitory activity against Adenosine A3 receptor by inhibiting specific [3H](R)-PIA binding to rat testis membranes |
CHEMBL1131221 |
| Rattus norvegicus |
IC50 |
= |
11.6 |
nM |
The compound was tested for the concentration to inhibit 50% of Adenylyl cyclase activity in rat cortical membranes. |
CHEMBL1131221 |
| Rattus norvegicus |
Max inhibition |
= |
15.5 |
% |
Maximal % inhibition of adenylyl cyclase activity in rat cortical membranes at a concentration of 10 uM. |
CHEMBL1131221 |
| Unchecked |
Selectivity |
= |
1327.0 |
|
Inhibitory selectivity at Adenosine 2A receptor compared to Adenosine 1 receptor. |
CHEMBL1131221 |
| Unchecked |
Selectivity |
= |
89.0 |
|
Inhibitory selectivity at Adenosine A3 receptor compared to Adenosine 1 receptor. |
CHEMBL1131221 |
| Unchecked |
Selectivity |
= |
0.06 |
|
Inhibitory selectivity at Adenosine A3 receptor compared to Adenosine 2A receptor. |
CHEMBL1131221 |
| Adenosine A3 receptor |
EC50 |
= |
242.0 |
nM |
Effect on forskolin-stimulated cyclic AMP production in intact chinese hamster ovary (CHO) cell expressing the human Adenosine A3 receptor |
CHEMBL1135592 |
| Adenosine A3 receptor |
Efficacy |
= |
97.0 |
% |
Percent efficacy against human Adenosine A3 receptor expressed in CHO cell |
CHEMBL1135592 |
| Adenosine A3 receptor |
Ki |
= |
72.0 |
nM |
Affinity for human Adenosine A3 receptor expressed in CHO cell |
CHEMBL1135592 |
| Adenosine A3 receptor |
Ki |
= |
142.0 |
nM |
Binding affinity towards human Adenosine A3 receptor wild type |
CHEMBL1135592 |
| Adenosine A3 receptor |
Ki |
= |
615.0 |
nM |
Binding affinity towards Adenosine A3 receptor (H95A mutant receptor) |
CHEMBL1135592 |
| Adenosine A3 receptor |
Ki |
= |
137.0 |
nM |
Binding affinity towards Adenosine A3 receptor (W243 A mutant receptor) |
CHEMBL1135592 |
| Adenosine A1 receptor |
Ki |
= |
0.32 |
nM |
Inhibition of N6-[3H]cyclohexyladenosine binding to guinea pig forebrain membrane Adenosine A1 receptor |
CHEMBL1126169 |
| Adenosine A1 receptor |
Ki |
= |
0.59 |
nM |
Binding affinity against Adenosine A1 receptor using N6-[3H]cyclohexyladenosine in rat brain membranes |
CHEMBL1126169 |
| Adenosine A1 receptor |
Ki |
= |
230.0 |
nM |
Binding affinity towards rat Adenosine A1 receptor using [3H]-DPCPX |
CHEMBL1134240 |
| Adenosine A1 receptor |
IC50 |
= |
0.3236 |
nM |
Evaluated for binding affinity against Adenosine A1 receptor |
CHEMBL1126162 |
| Adenosine A1 receptor |
Ki |
= |
5.9 |
nM |
Affinity for the Adenosine A1 receptor in the absence of GTP (A1-GTP) by using [3H]DPCPX as radioligand |
CHEMBL1128455 |
| Adenosine A1 receptor |
Ki |
= |
35.2 |
nM |
Affinity for the Adenosine A1 receptor in the presence of GTP (A1+GTP) by using [3H]-DPCPX as radioligand |
CHEMBL1128455 |
| Rattus norvegicus |
GTP shift |
= |
6.0 |
|
GTP shift was determined in rat |
CHEMBL1128455 |
| Adenosine A2a receptor |
Ki |
= |
580.0 |
nM |
Binding affinity against Adenosine A2A receptor by using [3H]CGS-21680 as radioligand |
CHEMBL1128455 |
| Adenosine A1 receptor |
Ki |
= |
0.3 |
nM |
Inhibition of [3H]CHA (N6-cyclohexyl adenosine) to rat brain membrane Adenosine A1 receptor |
CHEMBL1135881 |
| Adenosine A2a receptor |
Ki |
= |
380.0 |
nM |
Affinity to Adenosine A2A receptor of rat brain striatum using [3H]-CGS- 21680 |
CHEMBL1135881 |
| Adenosine A3 receptor |
Ki |
= |
260.0 |
nM |
Affinity to Adenosine A3 receptor of rat testis membrane using [3H](R)-PIA with 150 nM DPCPX |
CHEMBL1135881 |
| Rattus norvegicus |
IC50 |
= |
12.0 |
nM |
Inhibition of Adenylyl cyclase activity in rat cortical membranes |
CHEMBL1135881 |
| Rattus norvegicus |
Max inhibition |
= |
15.5 |
% |
% maximal inhibition of Adenylyl cyclase activity in rat cortical membranes at 10 uM |
CHEMBL1135881 |
| Adenosine receptors; A1 & A2a |
Selectivity |
= |
1266.0 |
|
Selectivity for Adenosine A2A over Adenosine A1 receptor |
CHEMBL1135881 |
| Adenosine receptors; A1 & A3 |
Selectivity |
= |
87.0 |
|
Selectivity for Adenosine A3 over Adenosine A1 receptor |
CHEMBL1135881 |
| Adenosine receptor A2a and A3 |
Selectivity |
= |
0.07 |
|
Selectivity towards Adenosine A3 receptor to Adenosine A2A receptor |
CHEMBL1135881 |
| Adenosine A1 receptor |
Ki |
= |
0.59 |
nM |
Binding affinity against Adenosine A1 receptor using [3H]CHA in rat brain membranes |
CHEMBL1124342 |
| Adenosine A2 receptor |
Ki |
= |
462.0 |
nM |
Binding affinity against Adenosine A2 receptor using [3H]NECA with 50 nM CPA in rat striatal brain membranes |
CHEMBL1124342 |
| Adenosine receptors; A1 & A2 |
Ratio |
= |
780.0 |
|
Ratio of binding affinities against Adenosine A2 and A1 receptors |
CHEMBL1124342 |
| Adenosine A1 receptor |
Ki |
= |
0.6 |
nM |
Affinity for Adenosine A1 receptor determined by [3H]N6-cyclohexyladenosine binding to rat brain membranes |
CHEMBL1126005 |
| Adenosine A2 receptor |
Ki |
= |
462.0 |
nM |
Affinity for Adenosine A2 receptor determined by [3H]NECA binding to rat striatal membranes |
CHEMBL1126005 |
| Adenosine receptors; A1 & A2 |
Ratio |
= |
783.0 |
|
Binding affinity ratio for A2 receptor and to that of A1 receptor in rat |
CHEMBL1126005 |
| Adenosine A1 receptor |
Ki |
= |
0.45 |
nM |
Inhibition of [3H]- (R)-P1A binding to adenosine A1 receptor |
CHEMBL1125222 |
| Adenosine A2 receptor |
Ki |
= |
510.0 |
nM |
Inhibition of [3H]- NECA binding to adenosine receptor A2 |
CHEMBL1125222 |
| Unchecked |
IC50 |
= |
3200.0 |
nM |
Effective concentration against A2AR mediated P12 adenylatencyclase activity |
CHEMBL1125222 |
| Adenosine receptors; A1 & A2a |
Ratio |
= |
1132.0 |
|
Ratio of binding potencies at adenosine A2AR and AIAR receptors |
CHEMBL1125222 |
| Adenosine A1 receptor |
Ki |
= |
1.21 |
nM |
Binding affinity against adenosine A1 receptor in rat brain membranes using [3H]CHA as radioligand |
CHEMBL1126140 |
| Adenosine A2 receptor |
Ki |
= |
421.0 |
nM |
Binding affinity against adenosine A2 receptor in rat striatal membranes using [3H]NECA as radioligand |
CHEMBL1126140 |
| Rattus norvegicus |
ED30 |
= |
0.5 |
ug kg-1 |
Dose producing 30% decrease of blood pressure in anesthetized rats (SHR) |
CHEMBL1126140 |
| Rattus norvegicus |
ED10 |
= |
0.14 |
ug kg-1 |
Dose producing 10% decrease of heart rate in anesthetized rats (SHR) |
CHEMBL1126140 |
| Adenosine receptors; A1 & A2 |
Selectivity |
= |
0.003 |
|
Selectivity against adenosine A1 to A2 receptors |
CHEMBL1126140 |
| Adenosine A1 receptor |
IC50 |
= |
1.0 |
nM |
Concentration required for 50% inhibition of [3H]-CHA binding on rat brain adenosine A1 receptor |
CHEMBL1125861 |
| Adenosine A2 receptor |
IC50 |
= |
1160.0 |
nM |
Concentration required for 50% inhibition of [3H]NECA binding on rat brain adenosine A2 receptor |
CHEMBL1125861 |
| Rattus norvegicus |
ED25 |
= |
0.004 |
mg kg-1 |
25% reduction in blood pressure in the rat. |
CHEMBL1125861 |
| Unchecked |
Delta HR |
= |
-25.0 |
% |
Change in heart rate was expressed in percent at at a dose 0.002 mg/kg iv in anesthetized rat |
CHEMBL1125861 |
| Rattus norvegicus |
Mean arterial blood pressure |
= |
159.0 |
mmHg |
Mean arterial pressure were recorded as baseline prior to the drug administration in hypertensive rats at 0.3 mg/kg dose |
CHEMBL1125861 |
| Rattus norvegicus |
Mean arterial blood pressure |
= |
-19.0 |
mmHg |
Mean arterial pressure were recorded as change after 6 hr of following oral dosing hypertensive rats at 0.3 mg/kg dose |
CHEMBL1125861 |
| Rattus norvegicus |
Mean arterial blood pressure |
= |
352.0 |
mmHg |
Heart rate was recorded as baseline prior to the drug administration in hypertensive rats at 0.3 mg/kg dose |
CHEMBL1125861 |
| Rattus norvegicus |
Mean arterial blood pressure |
= |
-53.0 |
mmHg |
Heart rate was recorded as change after 6 h of following oral dosing hypertensive rats at 0.3 mg/kg dose |
CHEMBL1125861 |
| Rattus norvegicus |
Mean arterial blood pressure |
= |
156.0 |
mmHg |
Mean arterial pressure were recorded as baseline prior to the drug administration in hypertensive rats at 1.0 mg/kg dose |
CHEMBL1125861 |
| Rattus norvegicus |
Mean arterial blood pressure |
= |
-71.0 |
mmHg |
Mean arterial pressure were recorded as change after 6 hr of following oral dosing hypertensive rats at 1.0 mg/kg dose |
CHEMBL1125861 |
| Rattus norvegicus |
Mean arterial blood pressure |
= |
334.0 |
mmHg |
Heart rate was recorded as baseline prior to the drug administration in hypertensive rats at 1.0 mg/kg dose |
CHEMBL1125861 |
| Rattus norvegicus |
Mean arterial blood pressure |
= |
-189.0 |
mmHg |
Heart rate was recorded as change after 6 hr of following oral dosing hypertensive rats at 1.0 mg/kg dose |
CHEMBL1125861 |
| Adenosine receptors; A1 & A2 |
Ratio |
= |
0.001 |
|
Ratio of IC50 values for A1 receptor binding to that of A2 receptor |
CHEMBL1125861 |
| Adenosine A1 receptor |
EC50 |
= |
12.59 |
nM |
Prolongation of the stimulus-QRS interval by 50% of the maximum response at the adenosine A1 receptor in langendorff guinea pig heart preparation |
CHEMBL1125661 |
| Adenosine A2 receptor |
EC50 |
= |
63.1 |
nM |
Coronary arteries vasodilation at the adenosine A2 receptor in langendorff guinea pig heart preparation |
CHEMBL1125661 |
| Adenosine receptors; A1 & A2 |
Ratio |
= |
0.3 |
|
Ratio of EC50 stim-QRS (conduction block) and EC50 for vasodilation of coronary arteries |
CHEMBL1125661 |
| Adenosine A1 receptor |
Ki |
= |
7.14 |
nM |
Affinity towards adenosine A1 receptor from rat cortical membranes using [3H]DPCPX |
CHEMBL1134582 |
| Adenosine A2a receptor |
Displacement |
= |
45.9 |
% |
Affinity towards Adenosine A2A receptor from rat striatal membranes using [3H]-ZM 241385 radioligand |
CHEMBL1134582 |
| Adenosine A3 receptor |
Ki |
= |
281.0 |
nM |
Affinity towards Adenosine A3 receptor expressed in HEK 293 cells using [125I]AB-MECA radioligand |
CHEMBL1134582 |
| Adenosine A1 receptor |
Inhibition |
= |
69.0 |
% |
Inhibition of 10 nM Forskolin-induced cAMP production at human Adenosine A1 receptor compared to CPA in CHO cells |
CHEMBL1134582 |
| Adenosine A1 receptor |
Activity |
= |
100.0 |
|
Agonistic activity expressed as the amount of [35S]-GTP gamma-S bound at rat Adenosine A1 receptor |
CHEMBL1134582 |
| Adenosine A1 receptor |
Activity |
= |
100.0 |
|
Agonistic activity expressed as the amount of [35S]-GTP gamma-S bound +1 uM CPA at rat Adenosine A1 receptor |
CHEMBL1134582 |
| Adenosine A1 receptor |
IC50 |
= |
640.0 |
nM |
Evaluated for the binding affinity towards the Adenosine A1 receptor in cerebral cortices of Sprague-Dawley male rats using [3H]CHA as radioligand. |
CHEMBL1124880 |
| Adenosine A1 receptor |
Ki |
= |
0.589 |
nM |
Evaluated for the binding affinity towards the Adenosine A1 receptor in corpora striata of rats using [3H]CHA as radioligand. |
CHEMBL1124880 |
| Adenosine A1 receptor |
Ki |
= |
462.0 |
nM |
Binding affinity for Adenosine A1 receptor in corpora striata of rats using [3H]NECA |
CHEMBL1124880 |
| Adenosine A1 receptor |
Ki |
= |
5.9 |
nM |
Binding affinity for Adenosine A1 receptor of rat cortical membrane by displacing [3H]DPCPX |
CHEMBL1132734 |
| Adenosine A2a receptor |
Ki |
= |
580.0 |
nM |
Binding affinity for adenosine A2A receptor of rat striatal membrane by displacing [3H]-ZM 241385 |
CHEMBL1132734 |
| Adenosine A3 receptor |
Ki |
= |
120.0 |
nM |
Binding affinity for Adenosine A3 receptor expressed in HEK 293 cells by displacing i[125I]-ABMECA |
CHEMBL1132734 |
| Adenosine A1 receptor |
Ki |
= |
0.59 |
nM |
Displacement of [3H]CHA from adenosine A1 receptor of rat whole brain |
CHEMBL1122939 |
| Adenosine A2 receptor |
Ki |
= |
462.0 |
nM |
Displacement of [3H]-NECA from adenosine A2 receptor of rat striatal membrane |
CHEMBL1122939 |
| No relevant target |
Log k |
= |
1.56 |
|
Lipophilicity value was evaluated |
CHEMBL1122939 |
| Adenosine receptors; A1 & A2 |
Ratio |
= |
783.0 |
|
Relative binding to A2 and A1 receptors (ratio of Ki) |
CHEMBL1122939 |
| Adenosine A1 receptor |
Ki |
= |
0.3 |
nM |
Ability to displace the specific binding of [3H]CHA to adenosine A1 receptor from bovine brain cortical membranes |
CHEMBL1132946 |
| Adenosine A2a receptor |
Ki |
= |
390.0 |
nM |
Ability to displace the specific binding of [3H]-CGS- to adenosine A2A receptor form bovine brain striatal membranes |
CHEMBL1132946 |
| Adenosine A3 receptor |
Ki |
= |
26.0 |
nM |
Ability to displace the specific binding of [3H](R)-PIA to adenosine A3 receptor from rat testis membranes |
CHEMBL1132946 |
| Unchecked |
Selectivity |
= |
1300.0 |
|
Selectivity, ratio of affinity towards adenosine A2A to A1 |
CHEMBL1132946 |
| Unchecked |
Selectivity |
= |
87.0 |
|
Selectivity, ratio of affinity towards adenosine A3 to A1 |
CHEMBL1132946 |
| Unchecked |
Selectivity |
= |
0.07 |
|
Selectivity, ratio of affinity towards adenosine A3 to A2A |
CHEMBL1132946 |
| Adenosine A1 receptor |
IC50 |
= |
11000.0 |
nM |
Inhibition of photolabeling of 34 kDa polypeptide in adenosine A1 receptor |
CHEMBL1124077 |
| Adenosine A1 receptor |
IC50 |
= |
14000.0 |
nM |
Inhibition of photolabeling of 24 kDa polypeptide in adenosine A1 receptor |
CHEMBL1124077 |
| Adenosine A1 receptor |
IC50 |
= |
58.0 |
nM |
Inhibition of Adenylate cyclase activity in rat fat cell membrane at adenosine A1 receptor |
CHEMBL1124132 |
| Adenosine A1 receptor |
Inhibition |
= |
0.99 |
% |
Maximal inhibition of adenylate cyclase activity relative to R-PIA for Adenosine A1 receptor (Inhibition by R-PIA=53+/-10%) |
CHEMBL1124132 |
| Adenosine A2 receptor |
EC50 |
= |
2200.0 |
nM |
Stimulation of adenylate cyclase activity in human platelet membrane at A2 receptor |
CHEMBL1124132 |
| Adenosine A2 receptor |
Stimulation |
= |
0.51 |
% |
Maximal stimulation of adenylate cyclase activity relative to NECA for A2-receptor. (Stimulation by NECA=250+/-30%) |
CHEMBL1124132 |
| Adenosine A1 receptor |
Ki |
= |
0.8 |
nM |
Displacement of [3H]PIA from adenosine A1 receptor of rat brain membranes |
CHEMBL1124132 |
| Adenosine A2 receptor |
Ki |
= |
2000.0 |
nM |
Displacement of [3H]NECA from A2-receptor of rat striatal membranes |
CHEMBL1124132 |
| Unchecked |
Selectivity |
= |
38.0 |
|
A1 selectivity as ratio of EC50 at A2 receptor to IC50 at A1 receptor |
CHEMBL1124132 |
| Adenosine receptors; A1 & A2 |
Selectivity |
= |
2500.0 |
|
A1 selectivity as ratio of Ki for A2 receptor to Ki for A1 receptor |
CHEMBL1124132 |
| Adenosine A1 receptor |
Ki |
= |
10.0 |
nM |
Displacement of [3H]DPCPX binding to human adenosine A1 receptor expressed in CHO cells |
CHEMBL1145202 |
| Adenosine A2a receptor |
Ki |
= |
790.0 |
nM |
Displacement of [3H]-ZM 241385 binding to human adenosine A2A receptor expressed in CHO cells |
CHEMBL1145202 |
| Adenosine A3 receptor |
Ki |
= |
281.0 |
nM |
Displacement of [125I]-AB-MECA binding to human adenosine A3 receptor expressed in HEK 293 cells |
CHEMBL1145202 |
| Adenosine A1 receptor |
Change in cAMP |
= |
-100.0 |
% |
Effect on forskolin-induced cAMP levels at human A1 adenosine receptor compared to CPA (full agonist, 100% inhibition) and DPCPX(full inverse agonist, 100% stimulation) |
CHEMBL1145202 |
| Equilibrative nucleoside transporter 1 |
Ki |
= |
1100.0 |
nM |
Inhibition of [3H]NBTI binding to equilibrative nucleoside transport protein 1 (ENT1) in human erythrocyte membranes |
CHEMBL1144396 |
| Adenosine A1 receptor |
Ki |
= |
0.45 |
nM |
Displacement of [3H]R-PIA or [3H]CGS 21680 from human adenosine A1 receptor in CHO cells |
CHEMBL1140427 |
| Adenosine A2a receptor |
Ki |
= |
462.0 |
nM |
Displacement of [3H]R-PIA or [3H]CGS 21680 from human adenosine A2A receptor in CHO cells |
CHEMBL1140427 |
| Adenosine A3 receptor |
Ki |
= |
240.0 |
nM |
Binding affinity to human adenosine A3 receptor in CHO cells |
CHEMBL1140427 |
| Adenosine A3 receptor |
Ki |
= |
97.0 |
nM |
Binding affinity to rat adenosine A3 receptor in CHO cells |
CHEMBL1140427 |
| Adenosine A3 receptor |
Activity |
= |
72.0 |
% |
Maximal agonist effect at human adenosine A3 receptor in CHO cells at 10 uM by the inhibition of forskolin-stimulated cAMP production |
CHEMBL1140427 |
| Adenosine A1 receptor |
Activity |
|
|
|
Activity at human adenosine A1 receptor expressed in CHO cells assessed as effect on forskolin-stimulated cAMP production at 100 nM |
CHEMBL1141417 |
| Adenosine A1 receptor |
Activity |
|
|
|
Activity at human adenosine A1 receptor expressed in CHO cells assessed as effect on forskolin-stimulated cAMP production at 1 uM |
CHEMBL1141417 |
| Adenosine A1 receptor |
Activity |
|
|
|
Reversal of agonistic activity at adenosine A1 receptor in embryonic rat H9C2 cell model of ischemia assessed as reduction of cardioprotective effect in presence of DPCPX A1 antagonist |
CHEMBL1139782 |
| Adenosine A1 receptor |
Activity |
= |
86.18 |
% |
Agonist activity at adenosine A1 receptor in embryonic rat H9C2 cell model of ischemia assessed as reduction of cell death at 10 nM |
CHEMBL1139782 |
| Adenosine A1 receptor |
Ki |
= |
0.4 |
nM |
Displacement of [3H]CCPA from adenosine A1 receptor in bovine cortical membrane |
CHEMBL1140761 |
| A1 adenosine receptor |
Ki |
= |
0.53 |
nM |
Displacement of [3H]CCPA from adenosine A1 receptor in pig cortical membrane |
CHEMBL1140761 |
| Adenosine A1 receptor |
Ki |
= |
1220.0 |
nM |
Displacement of [3H]CGS21680 from adenosine A1 receptor in bovine striatum membrane |
CHEMBL1140761 |
| A1 adenosine receptor |
EC50 |
= |
7.9 |
nM |
Agonist activity at adenosine A1 receptor in pig cortical membrane assessed as stimulation of GTPgammaS binding |
CHEMBL1140761 |
| A1 adenosine receptor |
Efficacy |
= |
100.0 |
% |
Agonist activity at adenosine A1 receptor in pig cortical membrane assessed as stimulation of GTPgammaS binding relative to CPA |
CHEMBL1140761 |
| Adenosine A1 receptor |
Ki |
= |
2.25 |
nM |
Displacement of [3H]CCPA from human recombinant adenosine A1 receptor expressed in CHO cells |
CHEMBL1140761 |
| Adenosine A2a receptor |
Ki |
= |
794.0 |
nM |
Displacement of [3H]NECA from human recombinant adenosine A2A receptor expressed in CHO cells |
CHEMBL1140761 |
| Adenosine A3 receptor |
Ki |
= |
18600.0 |
nM |
Displacement of [3H]NECA from human recombinant adenosine A3 receptor expressed in CHO cells |
CHEMBL1140761 |
| Adenosine A2b receptor |
Ki |
= |
43.0 |
nM |
Agonist activity at human recombinant adenosine A2B receptor expressed in CHO cells assessed as activation of adenylyl cyclase activity |
CHEMBL1140761 |
| Unchecked |
Ratio Ki |
= |
353.0 |
|
Selectivity for human adenosine A1 receptor over human adenosine A2A receptor |
CHEMBL1140761 |
| Adenosine receptors; A1 & A3 |
Ratio Ki |
= |
19.1 |
|
Selectivity for human adenosine A1 receptor over human adenosine A3 receptor |
CHEMBL1140761 |
| Unchecked |
Ratio Ki |
= |
18.5 |
|
Selectivity for human adenosine A3 receptor over human adenosine A2A receptor |
CHEMBL1140761 |
| A1 adenosine receptor |
Ki |
= |
810.0 |
nM |
Displacement of [3H]CGS21680 from adenosine A1 receptor in pig striatum membrane |
CHEMBL1140761 |
| Adenosine A1 receptor |
Ki |
= |
21.5 |
nM |
Displacement of [3H]CPX from adenosine A1 receptor in DDT1MF-2 cells |
CHEMBL1144002 |
| Adenosine A1 receptor |
IC50 |
= |
2.7 |
nM |
Agonist activity at adenosine A1 receptor assessed as inhibition of isoproterenol-stimulated cAMP accumulation in DDT1MF-2 cells |
CHEMBL1144002 |
| Adenosine A1 receptor |
Intrinsic activity |
= |
1.0 |
|
Intrinsic activity at adenosine A1 receptor assessed as maximal inhibition of isoproterenol-stimulated cAMP accumulation in DDT1MF-2 cells relative to CPA |
CHEMBL1144002 |
| Adenosine A1 receptor |
Ki |
= |
10.0 |
nM |
Displacement of [3H]DPCPX from human adenosine A1 receptor expressed in CHO cells |
CHEMBL1143999 |
| Adenosine A2a receptor |
Ki |
= |
1652.0 |
nM |
Displacement of [3H]ZM-241385 from human adenosine A2A receptor expressed in HEK293 cells |
CHEMBL1143999 |
| Adenosine A3 receptor |
Ki |
= |
281.0 |
nM |
Displacement of [3H]AB-MECA from human adenosine A3 receptor expressed in HEK293 cells |
CHEMBL1143999 |
| Adenosine A1 receptor |
Activity |
= |
51.0 |
% |
Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as inhibition of forskolin-stimulated cAMP production by TR-FRET assay |
CHEMBL1143999 |
| Adenosine A1 receptor |
Activity |
= |
193.0 |
% |
Agonist activity at adenosine A1 receptor in rat cortical membrane by [35S]GTPgammaS binding assay relative to control |
CHEMBL1150660 |
| Adenosine A1 receptor |
EC50 |
= |
16.9 |
nM |
Agonist activity at adenosine A1 receptor in rat cortical membrane by [35S]GTPgammaS binding assay |
CHEMBL1150660 |
| Adenosine A1 receptor |
Activity |
|
|
|
Agonist activity at human adenosine A1 receptor expressed in CHO cells assessed as inhibition of forskolin-stimulated cAMP accumulation by charcoal absorption assay |
CHEMBL1150660 |
| Unchecked |
Ki |
= |
9.0 |
nM |
Displacement of [3H]DPCPX from adenosine A1 receptor in Syrian hamster DDT1 MF2 cells |
CHEMBL1140105 |
| Adenosine A3 receptor |
Activity |
|
|
|
Agonist activity human recombinant adenosine A3 receptor expressed in CHO cells assessed as inhibition of forskolin-stimulated adenylyl cyclase activity |
CHEMBL1153422 |
| Adenosine A1 receptor |
Ki |
= |
10.0 |
nM |
Displacement of [3H]DPCPX from human adenosine A1 receptor expressed in CHO cell membrane |
CHEMBL1155896 |
| Adenosine A2a receptor |
Ki |
= |
1700.0 |
nM |
Displacement of [3H]ZM241385 from human adenosine A2A receptor expressed in HEK293 cell membrane |
CHEMBL1155896 |
| Adenosine A3 receptor |
Ki |
= |
280.0 |
nM |
Displacement of [3H]AB-MECA from human adenosine A3 receptor expressed in HEK293 cell membrane |
CHEMBL1155896 |
| K562 |
GI50 |
> |
250000.0 |
nM |
Antitumor activity against human K562 cells after 48 hrs by MTS assay |
CHEMBL1155110 |
| Caco-2 |
GI50 |
> |
250000.0 |
nM |
Antitumor activity against human CaCo2 cells after 48 hrs by MTS assay |
CHEMBL1155110 |
| HT-29 |
GI50 |
> |
250000.0 |
nM |
Antitumor activity against human HT29 cells after 48 hrs by MTS assay |
CHEMBL1155110 |
| MCF7 |
GI50 |
> |
250000.0 |
nM |
Antitumor activity against human MCF7 cells after 48 hrs by MTS assay |
CHEMBL1155110 |
| Adenosine A3 receptor |
Ki |
= |
3250.0 |
nM |
Displacement of [3H]PSB-11 from human adenosine A3 receptor expressed in CHO cells |
CHEMBL1157642 |
| Adenosine A2a receptor |
Ki |
= |
2470.0 |
nM |
Displacement of [3H]MSX2 from adenosine A2A receptor in rat brain striatum membrane |
CHEMBL1157642 |
| Adenosine A1 receptor |
Ki |
= |
0.8 |
nM |
Displacement of [3H]CCPA from adenosine A1 receptor in rat brain cortex membrane |
CHEMBL1157642 |
| Adenosine A1 receptor |
IC50 |
= |
7.09 |
nM |
Displacement of [3H]DPCPX from adenosine A1 receptor in rat brain cortical membrane in absence of 100 uM GTP |
CHEMBL1157642 |
| Adenosine A1 receptor |
IC50 |
= |
154.0 |
nM |
Displacement of [3H]DPCPX from adenosine A1 receptor in rat brain cortical membrane in presence of 100 uM GTP |
CHEMBL1157642 |
| Adenosine A1 receptor |
Ratio IC50 |
= |
21.9 |
|
Potency shift, ratio of IC50 for rat brain cortical membrane adenosine A1 receptor in presence of 100 uM GTP to C50 for rat brain cortical membrane adenosine A1 receptor in absence of 100 uM GTP |
CHEMBL1157642 |
| Adenosine A2b receptor |
Ki |
|
|
|
Displacement of [3H]PSB-603 from human adenosine A2B receptor expressed in CHO cells |
CHEMBL1157642 |
| Unchecked |
Inhibition |
|
|
% |
Inhibition of neurosphere proliferation of mouse neural precursor cells by MTT assay |
CHEMBL1255231 |
| Plasmodium falciparum |
IC50 |
= |
10000.0 |
nM |
Antiplasmodial activity against Plasmodium falciparum W2 after 72 hrs by SYBR green assay |
CHEMBL1255382 |
| Huntingtin |
Potency |
= |
2818.4 |
nM |
PUBCHEM_BIOASSAY: qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Aggregate Formation (GFP). (Class of assay: confirmatory) [Related pubchem assays: 1482, 1471 ] |
CHEMBL1201862 |
| microRNA 21 |
Potency |
= |
414.0 |
nM |
PUBCHEM_BIOASSAY: qHTS Assay for Modulators of miRNAs and/or Activators of miR-21. (Class of assay: confirmatory) |
CHEMBL1201862 |
| Unchecked |
Potency |
= |
23109.3 |
nM |
PUBCHEM_BIOASSAY: qHTS Assay for Lipid Storage Modulators in Drosophila S3 Cells. (Class of assay: confirmatory) |
CHEMBL1201862 |
| Beta-lactamase AmpC |
Potency |
= |
100000.0 |
nM |
PUBCHEM_BIOASSAY: qHTS Inhibitors of AmpC Beta-Lactamase (assay with detergent). (Class of assay: confirmatory) [Related pubchem assays: 1002 (Confirmation Concentration-Response Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent)), 585 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay without detergent) - a screen old NIH MLSMR collection), 584 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay with detergent) - a screen of the old NIH MLSMR collection), 1003 (Confirmation Cuvette-Based Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent))] |
CHEMBL1201862 |
| Lysosomal alpha-glucosidase |
Potency |
= |
6261.4 |
nM |
PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase Cleavage of Glycogen. (Class of assay: confirmatory) [Related pubchem assays: 1473, 1466 ] |
CHEMBL1201862 |
| microRNA 21 |
Potency |
= |
414.0 |
nM |
PUBCHEM_BIOASSAY: qHTS Assay for Modulators of miRNAs and/or Inhibitors of miR-21. (Class of assay: confirmatory) |
CHEMBL1201862 |
| Relaxin receptor 1 |
Potency |
= |
14125.4 |
nM |
PUBCHEM_BIOASSAY: qHTS Assay for Agonists of the Relaxin Receptor RXFP1. (Class of assay: confirmatory) |
CHEMBL1201862 |
| ATPase family AAA domain-containing protein 5 |
Potency |
|
5802.4 |
nM |
PUBCHEM_BIOASSAY: Validation screen for small molecules that induce genotoxicity in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493143, AID504466] |
CHEMBL1201862 |
| Relaxin receptor 2 |
Potency |
|
21862.1 |
nM |
PUBCHEM_BIOASSAY: qHTS Assay for Agonists of the Relaxin Receptor RXFP1: RXFP2 Hit Validation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2676, AID2703, AID489012] |
CHEMBL1201862 |
| Relaxin receptor 1 |
Potency |
|
9765.4 |
nM |
PUBCHEM_BIOASSAY: qHTS Assay for Agonists of the Relaxin Receptor RXFP1: RXFP1 Hit Validation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2676, AID2703, AID489043, AID492948] |
CHEMBL1201862 |
| Unchecked |
Potency |
|
1458.1 |
nM |
PUBCHEM_BIOASSAY: qHTS Assay to Find Inhibitors of Chronic Active B-Cell Receptor Signaling. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID485345, AID485355] |
CHEMBL1201862 |
| Histone-lysine N-methyltransferase, H3 lysine-9 specific 3 |
Potency |
|
7079.5 |
nM |
PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404] |
CHEMBL1201862 |
| Histone-lysine N-methyltransferase, H3 lysine-9 specific 3 |
Potency |
|
1122.0 |
nM |
PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404] |
CHEMBL1201862 |
| 6-phospho-1-fructokinase |
Potency |
|
37933.0 |
nM |
PUBCHEM_BIOASSAY: qHTS Validation Assay to Find Inhibitors of T. brucei phosphofructokinase. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488768, AID492961] |
CHEMBL1201862 |
| Chromobox protein homolog 1 |
Potency |
|
67015.8 |
nM |
PUBCHEM_BIOASSAY: qHTS Validation Assay for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962] |
CHEMBL1201862 |
| Vasopressin V1b receptor |
Potency |
|
30881.0 |
nM |
PUBCHEM_BIOASSAY: qHTS Assay for Agonists of the Relaxin Receptor RXFP1: V1B Hit Validation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2676, AID2703, AID489012] |
CHEMBL1201862 |
| Unchecked |
Potency |
|
580.5 |
nM |
PUBCHEM_BIOASSAY: qHTS Validation Assay to Find Inhibitors of Chronic Active B-Cell Receptor Signaling. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493014] |
CHEMBL1201862 |
| Chromobox protein homolog 1 |
Potency |
|
89125.1 |
nM |
PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962] |
CHEMBL1201862 |
| Thioredoxin reductase 1, cytoplasmic |
Potency |
|
631.0 |
nM |
PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488771] |
CHEMBL1201862 |
| Mothers against decapentaplegic homolog 3 |
Potency |
|
2511.9 |
nM |
PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860] |
CHEMBL1201862 |
| Unchecked |
Potency |
|
920.0 |
nM |
PUBCHEM_BIOASSAY: qHTS for inhibitors of binding or entry into cells for Marburg Virus. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249, AID540278] |
CHEMBL1201862 |
| Unchecked |
Potency |
|
1835.6 |
nM |
PubChem BioAssay. qHTS Assay to Find Inhibitors of Chronic Active B-Cell Receptor Signaling: Hit Validation in Primary Screen. (Class of assay: confirmatory) |
CHEMBL1201862 |
| Mus musculus |
Activity |
|
|
|
Cardiovascular toxicity in A1AR knock out C57BL/6 mouse assessed as change in body temperature at 5000 nmol/kg, po |
CHEMBL2163273 |
| Mus musculus |
Activity |
|
|
|
Cardiovascular toxicity in A1AR knock out C57BL/6 mouse assessed as change in heart rate at 5000 nmol/kg, po |
CHEMBL2163273 |
| Mus musculus |
Activity |
|
|
|
Cardiovascular toxicity in C57BL/6 mouse assessed as change in body temperature at 5000 nmol/kg, po |
CHEMBL2163273 |
| Mus musculus |
Activity |
|
|
|
Cardiovascular toxicity in C57BL/6 mouse assessed as change in heart rate at 5000 nmol/kg, po |
CHEMBL2163273 |
| Mus musculus |
Activity |
|
|
|
Antinociceptive effect in orally dosed C57BL/6 mouse assessed as inhibition of noxious thermal sensitivity by measuring paw withdrawal latency |
CHEMBL2163273 |
| Adenosine A1 receptor |
EC50 |
= |
6.3 |
nM |
Agonist activity at human A1AR expressed in HEK293T/17 cells assessed as inhibition of forskolin-induced cAMP accumulation incubated for 10 mins by luciferase reporter assay |
CHEMBL2163273 |
| Adenosine A1 receptor |
Inhibition |
= |
100.0 |
% |
Activity at human A1 adenosine receptor expressed in CHO cells assessed as inhibition of forskolin-stimulated cAMP production at 10 uM after 30 min |
CHEMBL2169760 |
| Adenosine A2a receptor |
Ki |
= |
794.0 |
nM |
Displacement of [3H]CGS21680 from human A2a adenosine receptor expressed in HEK293 cells after 60 min by Perkin Elmer Liquid Scintillation Analyzer |
CHEMBL2169760 |
| Adenosine A1 receptor |
Ki |
= |
1.8 |
nM |
Displacement of [3H]R-PIA from human A1 adenosine receptor expressed in CHO cells after 60 min by Perkin Elmer Liquid Scintillation Analyzer |
CHEMBL2169760 |
| Isocitrate dehydrogenase [NADP] cytoplasmic |
Potency |
|
29092.9 |
nM |
PubChem BioAssay. qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line. (Class of assay: confirmatory) |
CHEMBL1201862 |
| Adenosine A3 receptor |
Ki |
= |
72.0 |
nM |
Displacement of [125I]I-AB-MECA from human adenosine A3 receptor expressed in CHO cells after 90 mins by gamma counting analysis |
CHEMBL2412992 |
| Adenosine A3 receptor |
Ki |
= |
1490.0 |
nM |
Competitive binding affinity to human adenosine A3 receptor expressed in CHO cells after 90 mins by flow cytometric analysis in presence of MRS5449 |
CHEMBL2412992 |
| Adenosine A2a receptor |
Ki |
= |
794.0 |
nM |
Displacement of [3H]CGS21680 from human adenosine A2A receptor expressed in HEK293 cells after 60 mins by liquid scintillation counting analysis |
CHEMBL2412992 |
| Adenosine A2a receptor |
Ki |
= |
814.0 |
nM |
Competitive binding affinity to human adenosine A2A receptor expressed in HEK293 cells after 60 mins by fluorescence polarization assay in presence of MRS5346 |
CHEMBL2412992 |
| DNA-(apurinic or apyrimidinic site) lyase |
Potency |
|
35481.3 |
nM |
PubChem BioAssay. qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1). (Class of assay: confirmatory) |
CHEMBL1201862 |
| H9c2 |
Inhibition |
= |
75.4 |
% |
Cardioprotective activity in rat H9c2 cells hypoxia-induced ischaemic model assessed as maximal decrease in cell death at 10 uM by propidium iodide exclusion assay |
CHEMBL3217746 |
| Adenosine A1 receptor |
Ki |
= |
15.3 |
nM |
Displacement of [3H]-DPCPX from Adenosine A1 receptor in Sprague-Dawley rat whole brain membranes |
CHEMBL3616475 |
| Adenosine A2a receptor |
Ki |
= |
331.0 |
nM |
Displacement of [3H]-NECA from Adenosine A2A receptor in Sprague-Dawley rat striatal membranes |
CHEMBL3616475 |
| Unchecked |
Ratio Ki |
= |
22.0 |
|
Selectivity ratio of Ki for Adenosine A2A receptor in Sprague-Dawley rat striatal membranes to Ki for Adenosine A1 receptor in Sprague-Dawley rat whole brain membranes |
CHEMBL3616475 |
| Adenosine A1 receptor |
Ki |
= |
4.43 |
nM |
Displacement of [3H]-DPCPX from Adenosine A1 receptor in Sprague-Dawley rat brain cortical membranes in absence of GTP |
CHEMBL3616475 |
| Adenosine A1 receptor |
Ki |
= |
63.08 |
nM |
Displacement of [3H]-DPCPX from Adenosine A1 receptor in Sprague-Dawley rat brain cortical membranes in presence of 0.1 mM GTP |
CHEMBL3616475 |
| Adenosine A1 receptor |
Ratio Ki |
= |
14.24 |
|
Ratio of Ki for Adenosine A1 receptor in Sprague-Dawley rat brain cortical membranes in presence of 0.1 mM GTP to Ki for Adenosine A1 receptor in Sprague-Dawley rat brain cortical membranes in absence of GTP |
CHEMBL3616475 |
| Adenosine A1 receptor |
Ki |
= |
15.3 |
nM |
Displacement of [3H]-DPCPX from Adenosine A1 receptor in Sprague-Dawley rat whole brain membranes in absence of GTP |
CHEMBL3616475 |
| Adenosine A1 receptor |
Ki |
= |
99.21 |
nM |
Displacement of [3H]-DPCPX from Adenosine A1 receptor in Sprague-Dawley rat whole brain membranes in presence of 0.1 mM GTP |
CHEMBL3616475 |
| Adenosine A1 receptor |
Ratio Ki |
= |
6.48 |
|
Ratio of Ki for Adenosine A1 receptor in Sprague-Dawley rat whole brain membranes in presence of 0.1 mM GTP to Ki for Adenosine A1 receptor in Sprague-Dawley rat whole brain membranes in absence of GTP |
CHEMBL3616475 |
| Adenosine A1 receptor |
Ki |
= |
7.9 |
nM |
Displacement of [3H]-DPCPX from Adenosine A1 receptor in rat whole brain membranes |
CHEMBL3616475 |
| Adenosine A2a receptor |
Ki |
= |
460.0 |
nM |
Displacement of [3H]-NECA from Adenosine A2A receptor in rat striatal membranes |
CHEMBL3616475 |
| Adenosine A1 receptor |
Ki |
= |
5.9 |
nM |
Displacement of [3H]-DPCPX from Adenosine A1 receptor in rat brain cortical membranes in absence of GTP |
CHEMBL3616475 |
| Adenosine A1 receptor |
Ki |
= |
35.2 |
nM |
Displacement of [3H]-DPCPX from Adenosine A1 receptor in rat brain cortical membranes in presence of GTP |
CHEMBL3616475 |
| Adenosine A1 receptor |
Ratio Ki |
= |
6.0 |
|
Ratio of Ki for Adenosine A1 receptor in rat brain cortical membranes in presence of GTP to Ki for Adenosine A1 receptor in brain cortical membranes in absence of GTP |
CHEMBL3616475 |
| Adenosine A1 receptor |
Ki |
= |
10.4 |
nM |
Displacement of [3H]DPCPX from adenosine A1 receptor in Sprague-Dawley rat whole brain membranes after 1 hr by scintillation counting analysis |
CHEMBL3734685 |
| Adenosine A1 receptor |
Ki |
= |
8.48 |
nM |
Displacement of [3H]DPCPX from adenosine A1 receptor in Sprague-Dawley rat whole brain after 1 hr by scintillation counting |
CHEMBL3751667 |
| Adenosine A1 receptor |
Ki |
= |
5.9 |
nM |
Binding affinity to adenosine A1 receptor (unknown origin) |
CHEMBL3769306 |
| Adenosine A3 receptor |
Ki |
= |
72.0 |
nM |
Binding affinity to Adenosine receptor A3 (unknown origin) |
CHEMBL3774335 |
| Adenosine A1 receptor |
Ki |
= |
2.3 |
nM |
Radioligand Binding Assay: Membranes for radioligand binding experiments are prepared from fresh or frozen cells as described in Klotz et al., Naunyn-Schmiedeberg's Arch. Pharmacol, 357:1-9 (1998). The cell suspension is then homogenized in ice-cold hypotonic buffer (5 mM Tris/HCl, 2 mM EDTA, pH 7.4) and the homogenate is spun for 10 minutes (4° C.) at 1,000 g. The membranes are then sedimented from the supernatant for 30 minutes at 100,000 g and resuspended in 50 mM Tris/HCl buffer pH 7.4 (for A3 adenosine receptors: 50 mM Tris/HCl, 10 mM MgCl2, 1 mM EDTA, pH 8.25), frozen in liquid nitrogen at a protein concentration of 1-3 mg/mL and stored at −80° C. Dissociation constants of unlabeled compounds (Ki-values) are determined in competition experiments in 96-well microplates using the A1 selective agonist 2-chloro-N6-[3H]cyclopentyladenosine ([3H]CCPA, 1 nM) for the characterization of A1 receptor binding. Nonspecific binding is determined in the presence of 100 μM R-PM and 1 mM theophylline, respectively. |
CHEMBL3638797 |
| SARS-CoV-2 |
Inhibition |
= |
-0.52 |
% |
Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of Caco-2 cells at 10 uM after 48 hours by high content imaging |
CHEMBL4303101 |
| Adenosine A3 receptor |
Ki |
= |
72.0 |
nM |
Displacement of [125I]I-AB-MECA from recombinant human adenosine A3 receptor expressed in CHO cell membranes |
CHEMBL4368860 |
| Adenosine A2a receptor |
Ki |
= |
794.0 |
nM |
Displacement of [3H]ZM241385 from human A2A receptor expressed in HEK293 cell membranes |
CHEMBL4368860 |
| Adenosine A1 receptor |
Ki |
= |
2.3 |
nM |
Displacement of [3H]DPCPX from recombinant human A1 receptor expressed in CHO cell membranes |
CHEMBL4368860 |
| Adenosine A1 receptor |
Ki |
= |
2.3 |
nM |
Displacement of [3H]N6-R-phenylisopropyladenosine from human A1A adenosine receptor expressed in CHO cell membranes after 60 mins by scintillation proximity assay |
CHEMBL4368904 |
| Adenosine A1 receptor |
Ki |
= |
0.22 |
nM |
Displacement of [3H]N6-R-phenylisopropyladenosine from mouse A1A adenosine receptor expressed in CHO cell membranes after 60 mins by scintillation proximity assay |
CHEMBL4368904 |
| Adenosine A2a receptor |
Ki |
= |
794.0 |
nM |
Displacement of [3H]2-[p-(2-carboxyethyl)phenylethylamino]-5-N-ethylcarboxamidoadenosine from human A2A adenosine receptor expressed in HEK293 cell membranes after 60 mins by scintillation proximity assay |
CHEMBL4368904 |
| Adenosine A2a receptor |
Ki |
= |
808.0 |
nM |
Displacement of [3H]2-[p-(2-carboxyethyl)phenylethylamino]-5-N-ethylcarboxamidoadenosine from mouse A2A adenosine receptor expressed in HEK293 cell membranes after 60 mins by scintillation proximity assay |
CHEMBL4368904 |
| Adenosine A3 receptor |
Ki |
= |
72.0 |
nM |
Displacement of [125I]N6-(4-amino-3-iodobenzyl)adenosine-5-N-methyluronamide from human A3A adenosine receptor expressed in CHO cell membranes after 60 mins by scintillation proximity assay |
CHEMBL4368904 |
| Adenosine A3 receptor |
Ki |
= |
534.0 |
nM |
Displacement of [125I]N6-(4-amino-3-iodobenzyl)adenosine-5-N-methyluronamide from mouse A3A adenosine receptor expressed in CHO cell membranes after 60 mins by scintillation proximity assay |
CHEMBL4368904 |
| Mus musculus |
T |
= |
32.4 |
degrees C |
Induction of hypothermia in C57BL/6J mouse assessed as body temperature at 1 mg/kg, ip measured at 60 mins post dose (Rvb = 36.3 +/- 0.8 degC) |
CHEMBL4368904 |
| Mus musculus |
Activity |
= |
1.5 |
|
Induction of hypothermia in C57BL/6J mouse assessed as activity counts at 1 mg/kg, ip measured at 60 mins post dose (Rvb = 15.5 +/- 5.5 No_unit) |
CHEMBL4368904 |
| Adenosine A1 receptor |
Ki |
= |
6.8 |
nM |
Displacement of [3H]DPCPX from adenosine A1 receptor in rat brain membranes by radioligand competition assay |
CHEMBL4480374 |
| Adenosine A2a receptor |
Ki |
= |
163.0 |
nM |
Displacement of [3H]NECA from adenosine A2A receptor in rat striatal membranes by radioligand competition assay |
CHEMBL4480374 |
| Unchecked |
Ratio Ki |
= |
24.0 |
|
Selectivity index, ratio of Ki for adenosine A1 receptor in rat brain membranes to Ki for adenosine A2A receptor in rat striatal membranes |
CHEMBL4480374 |
| Adenosine A1 receptor |
Ki |
= |
7.9 |
nM |
Displacement of [3H]CHA from adenosine A1 receptor in rat brain membranes |
CHEMBL4480374 |
| Adenosine A1 receptor |
Ki |
= |
99.0 |
nM |
Displacement of [3H]DPCPX from adenosine A1 receptor in rat brain membranes in presence of GTP by radioligand competition assay |
CHEMBL4480374 |
| Adenosine A1 receptor |
Ratio Ki |
= |
15.0 |
|
Selectivity index, ratio of Ki for adenosine A1 receptor in rat brain membranes in presence of GTP to Ki for adenosine A1 receptor in rat brain membranes in absence of GTP |
CHEMBL4480374 |
| Replicase polyprotein 1ab |
Inhibition |
= |
16.79 |
% |
SARS-CoV-2 3CL-Pro protease inhibition percentage at 20µM by FRET kind of response from peptide substrate |
CHEMBL4495564 |
| SARS-CoV-2 |
Inhibition |
= |
-0.3 |
% |
Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging |
CHEMBL4495565 |
| Adenosine A1 receptor |
Ki |
= |
5.1 |
nM |
Displacement of [3H]DPCPX from Sprague-Dawley rat whole brain membrane A1AR by scintillation counting analysis |
CHEMBL4622929 |
| Adenosine A2a receptor |
Ki |
= |
557.0 |
nM |
Displacement of [3H]NECA from Sprague-Dawley rat striatal membrane A2A adenosine receptor by scintillation counting analysis |
CHEMBL4622929 |
| Adenosine A1 receptor |
Ki |
= |
29500.0 |
nM |
Displacement of [3H]DPCPX from Sprague-Dawley rat whole brain membrane A1AR in presence of GTP by radioligand binding assay |
CHEMBL4622929 |
| Adenosine A1 receptor |
Ratio Ki |
= |
5.8 |
|
Ratio of Ki for displacement of [3H]DPCPX from Sprague-Dawley rat whole brain membrane A1AR in presence of GTP to Ki for displacement of [3H]DPCPX from Sprague-Dawley rat whole brain A1AR |
CHEMBL4622929 |
| Unchecked |
Ratio Ki |
= |
5784.0 |
|
Selectivity index, ratio of Ki for Sprague-Dawley rat striatal membrane A2 adenosine receptor to Ki for Sprague-Dawley rat whole brain A1 adenosine receptor |
CHEMBL4622929 |
| Adenosine A1 receptor |
Ki |
= |
7.9 |
nM |
Displacement of [3H]PD116948 from Long-Evans rat whole brain membrane A1AR incubated for 60 mins by liquid scintillation counting analysis |
CHEMBL4622929 |
| Adenosine A2a receptor |
Ki |
= |
460.0 |
nM |
Displacement of [3H]NECA from rat striatal A2A adenosine receptor |
CHEMBL4622929 |
| SARS-CoV-2 |
Inhibition |
= |
-0.3 |
% |
Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging |
CHEMBL4495565 |
| SARS-CoV-2 |
IC50 |
> |
20000.0 |
nM |
Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging |
CHEMBL4651402 |
| SARS-CoV-2 |
IC50 |
< |
19952.62 |
nM |
Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging |
CHEMBL4651402 |
| Adenosine A1 receptor |
IC50 |
= |
64.7 |
nM |
Displacement of [3H]DPCPX from rat brain cortical membrane A1AR in absence of GTP by scintillation counting analysis |
CHEMBL4680130 |
| Adenosine A1 receptor |
IC50 |
= |
537.6 |
nM |
Displacement of [3H]DPCPX from rat brain cortical membrane A1AR in presence of 100 uM of GTP by scintillation counting analysis |
CHEMBL4680130 |
| Adenosine A1 receptor |
IC50 |
= |
8.3 |
nM |
Displacement of [3H]DPCPX from rat brain cortical membrane A1AR assessed as GTP shift |
CHEMBL4680130 |
| HEK-293T |
Cell Viability |
= |
-0.12 |
|
Incucyte cell viability with HEK293T |
CHEMBL5058564 |
| HEK-293T |
Cell Viability |
= |
-0.14 |
|
Incucyte cell viability with HEK293T |
CHEMBL5058564 |
| U2OS |
Cell Viability |
= |
1.84 |
|
Incucyte cell viability with U2OS |
CHEMBL5058564 |
| U2OS |
Cell Viability |
= |
2.45 |
|
Incucyte cell viability with U2OS |
CHEMBL5058564 |
| Fibroblasts |
Cell Viability |
= |
0.37 |
|
Incucyte cell viability with human fibroblast |
CHEMBL5058564 |
| Fibroblasts |
Cell Viability |
= |
-0.09 |
|
Incucyte cell viability with human fibroblast |
CHEMBL5058564 |
| HEK-293T |
Cell Viability |
= |
0.92 |
|
Incucyte cell viability with HEK293T |
CHEMBL5058564 |
| HEK-293T |
Cell Viability |
= |
0.12 |
|
Incucyte cell viability with HEK293T |
CHEMBL5058564 |
| U2OS |
Cell Viability |
= |
0.36 |
|
Incucyte cell viability with U2OS |
CHEMBL5058564 |
| U2OS |
Cell Viability |
= |
0.74 |
|
Incucyte cell viability with U2OS |
CHEMBL5058564 |
| Fibroblasts |
Cell Viability |
= |
2.34 |
|
Incucyte cell viability with human fibroblast |
CHEMBL5058564 |
| Fibroblasts |
Cell Viability |
= |
2.33 |
|
Incucyte cell viability with human fibroblast |
CHEMBL5058564 |
| HEK-293T |
Cell Viability |
= |
0.81 |
|
Incucyte cell viability with HEK293T |
CHEMBL5058564 |
| HEK-293T |
Cell Viability |
= |
0.6 |
|
Incucyte cell viability with HEK293T |
CHEMBL5058564 |
| U2OS |
Cell Viability |
= |
0.69 |
|
Incucyte cell viability with U2OS |
CHEMBL5058564 |
| U2OS |
Cell Viability |
= |
0.94 |
|
Incucyte cell viability with U2OS |
CHEMBL5058564 |
| Fibroblasts |
Cell Viability |
= |
2.18 |
|
Incucyte cell viability with human fibroblast |
CHEMBL5058564 |
| Fibroblasts |
Cell Viability |
= |
1.44 |
|
Incucyte cell viability with human fibroblast |
CHEMBL5058564 |
| HEK-293T |
Cell Viability |
= |
0.75 |
|
Incucyte cell viability with HEK293T |
CHEMBL5058564 |
| HEK-293T |
Cell Viability |
= |
0.65 |
|
Incucyte cell viability with HEK293T |
CHEMBL5058564 |
| U2OS |
Cell Viability |
= |
0.53 |
|
Incucyte cell viability with U2OS |
CHEMBL5058564 |
| U2OS |
Cell Viability |
= |
0.93 |
|
Incucyte cell viability with U2OS |
CHEMBL5058564 |
| Fibroblasts |
Cell Viability |
= |
1.38 |
|
Incucyte cell viability with human fibroblast |
CHEMBL5058564 |
| Fibroblasts |
Cell Viability |
= |
1.09 |
|
Incucyte cell viability with human fibroblast |
CHEMBL5058564 |
| HEK-293T |
Cell Viability |
= |
0.73 |
|
Incucyte cell viability with HEK293T |
CHEMBL5058564 |
| HEK-293T |
Cell Viability |
= |
0.66 |
|
Incucyte cell viability with HEK293T |
CHEMBL5058564 |
| U2OS |
Cell Viability |
= |
0.71 |
|
Incucyte cell viability with U2OS |
CHEMBL5058564 |
| U2OS |
Cell Viability |
= |
1.0 |
|
Incucyte cell viability with U2OS |
CHEMBL5058564 |
| Fibroblasts |
Cell Viability |
= |
1.27 |
|
Incucyte cell viability with human fibroblast |
CHEMBL5058564 |
| Fibroblasts |
Cell Viability |
= |
0.92 |
|
Incucyte cell viability with human fibroblast |
CHEMBL5058564 |
| Tyrosine-protein kinase ABL |
Delta TM |
= |
0.76 |
C |
Thermal Shift Assay. Domain: start/stop: S229-K512 |
CHEMBL4632348 |
| Serine/threonine-protein kinase Aurora-A |
Delta TM |
= |
-0.15 |
C |
Thermal Shift Assay. Domain: start/stop: E122-S403 |
CHEMBL4632348 |
| Bromodomain-containing protein 4 |
Delta TM |
= |
-1.77 |
C |
Thermal Shift Assay. Domain: start/stop: N44-E168 |
CHEMBL4632348 |
| Peregrin |
Delta TM |
= |
-1.53 |
C |
Thermal Shift Assay. Domain: start/stop: M626-G740 |
CHEMBL4632348 |
| Cyclin-dependent kinase 2 |
Delta TM |
= |
0.75 |
C |
Thermal Shift Assay. Domain: start/stop: M1-L298 |
CHEMBL4632348 |
| Casein kinase I delta |
Delta TM |
= |
0.13 |
C |
Thermal Shift Assay. Domain: start/stop: M1-K294 |
CHEMBL4632348 |
| Fibroblast growth factor receptor 3 |
Delta TM |
= |
0.34 |
C |
Thermal Shift Assay. Domain: start/stop: P449-E759 |
CHEMBL4632348 |
| Glycogen synthase kinase-3 beta |
Delta TM |
= |
-0.13 |
C |
Thermal Shift Assay. Domain: start/stop: M26-R383 |
CHEMBL4632348 |
| MAP kinase ERK2 |
Delta TM |
= |
0.01 |
C |
Thermal Shift Assay. Domain: start/stop: M1-S360 |
CHEMBL4632348 |
| Transcription intermediary factor 1-alpha |
Delta TM |
= |
0.43 |
C |
Thermal Shift Assay. Domain: start/stop: G861-E979 |
CHEMBL4632348 |
| Adhesion G-protein coupled receptor F1 |
%Max (Mean) |
= |
31.61 |
% |
GPCR beta-arrestin recruitment assay with target: ADGRF1 Assay Type: PRESTO-Tango Concentration: 0.00001 |
CHEMBL5209801 |
| Adhesion G-protein coupled receptor F1 |
%Inhib (Mean) |
= |
3.74 |
% |
GPCR beta-arrestin recruitment assay with target: ADGRF1 Assay Type: PRESTO-Tango Concentration: 0.00001 |
CHEMBL5209801 |
| G-protein coupled receptor 120 |
%Max (Mean) |
= |
3.579 |
% |
GPCR beta-arrestin recruitment assay with target: FFAR4 Assay Type: PRESTO-Tango Concentration: 0.00001 |
CHEMBL5209801 |
| G-protein coupled receptor 120 |
%Inhib (Mean) |
= |
-52.88 |
% |
GPCR beta-arrestin recruitment assay with target: FFAR4 Assay Type: PRESTO-Tango Concentration: 0.00001 |
CHEMBL5209801 |
| Beta-2 adrenergic receptor |
%Max (Mean) |
= |
-1.7819999999999998 |
% |
GPCR beta-arrestin recruitment assay with target: ADRB2 Assay Type: PRESTO-Tango Concentration: 0.00001 |
CHEMBL5209801 |
| Beta-2 adrenergic receptor |
%Inhib (Mean) |
= |
-22.46 |
% |
GPCR beta-arrestin recruitment assay with target: ADRB2 Assay Type: PRESTO-Tango Concentration: 0.00001 |
CHEMBL5209801 |
| G-protein coupled receptor 35 |
%Max (Mean) |
= |
-0.4579 |
% |
GPCR beta-arrestin recruitment assay with target: GPR35 Assay Type: PRESTO-Tango Concentration: 0.00001 |
CHEMBL5209801 |
| G-protein coupled receptor 35 |
%Inhib (Mean) |
= |
-24.79 |
% |
GPCR beta-arrestin recruitment assay with target: GPR35 Assay Type: PRESTO-Tango Concentration: 0.00001 |
CHEMBL5209801 |
| C-X3-C chemokine receptor 1 |
%Max (Mean) |
= |
-2.41 |
% |
GPCR beta-arrestin recruitment assay with target: CX3CR1 Assay Type: PRESTO-Tango Concentration: 0.00001 |
CHEMBL5209801 |
| C-X3-C chemokine receptor 1 |
%Inhib (Mean) |
= |
-48.12 |
% |
GPCR beta-arrestin recruitment assay with target: CX3CR1 Assay Type: PRESTO-Tango Concentration: 0.00001 |
CHEMBL5209801 |
| Alpha-2a adrenergic receptor |
%Max (Mean) |
= |
-0.8 |
% |
GPCR beta-arrestin recruitment assay with target: ADRA2A Assay Type: PRESTO-Tango Concentration: 0.00001 |
CHEMBL5209801 |
| Alpha-2a adrenergic receptor |
%Inhib (Mean) |
= |
-35.76 |
% |
GPCR beta-arrestin recruitment assay with target: ADRA2A Assay Type: PRESTO-Tango Concentration: 0.00001 |
CHEMBL5209801 |
| Glucose-dependent insulinotropic receptor |
%Max (Mean) |
= |
-2.071 |
% |
GPCR beta-arrestin recruitment assay with target: GPR119 Assay Type: PRESTO-Tango Concentration: 0.00001 |
CHEMBL5209801 |
| Glucose-dependent insulinotropic receptor |
%Inhib (Mean) |
= |
-10.48 |
% |
GPCR beta-arrestin recruitment assay with target: GPR119 Assay Type: PRESTO-Tango Concentration: 0.00001 |
CHEMBL5209801 |
| Lipoxin A4 receptor |
%Max (Mean) |
= |
-2.5610000000000004 |
% |
GPCR beta-arrestin recruitment assay with target: FPR2 Assay Type: PRESTO-Tango Concentration: 0.00001 |
CHEMBL5209801 |
| Lipoxin A4 receptor |
%Inhib (Mean) |
= |
-12.61 |
% |
GPCR beta-arrestin recruitment assay with target: FPR2 Assay Type: PRESTO-Tango Concentration: 0.00001 |
CHEMBL5209801 |
| Sphingosine 1-phosphate receptor Edg-1 |
%Max (Mean) |
= |
-1.03 |
% |
GPCR beta-arrestin recruitment assay with target: S1PR1 Assay Type: PRESTO-Tango Concentration: 0.00001 |
CHEMBL5209801 |
| Sphingosine 1-phosphate receptor Edg-1 |
%Inhib (Mean) |
= |
-43.0 |
% |
GPCR beta-arrestin recruitment assay with target: S1PR1 Assay Type: PRESTO-Tango Concentration: 0.00001 |
CHEMBL5209801 |
| Apelin receptor |
%Max (Mean) |
= |
-2.5810000000000004 |
% |
GPCR beta-arrestin recruitment assay with target: APLNR Assay Type: PRESTO-Tango Concentration: 0.00001 |
CHEMBL5209801 |
| Apelin receptor |
%Inhib (Mean) |
= |
4.68 |
% |
GPCR beta-arrestin recruitment assay with target: APLNR Assay Type: PRESTO-Tango Concentration: 0.00001 |
CHEMBL5209801 |
| C5a anaphylatoxin chemotactic receptor |
%Max (Mean) |
= |
-2.341 |
% |
GPCR beta-arrestin recruitment assay with target: C5AR1 Assay Type: PRESTO-Tango Concentration: 0.00001 |
CHEMBL5209801 |
| C5a anaphylatoxin chemotactic receptor |
%Inhib (Mean) |
= |
-12.09 |
% |
GPCR beta-arrestin recruitment assay with target: C5AR1 Assay Type: PRESTO-Tango Concentration: 0.00001 |
CHEMBL5209801 |
| Glucagon-like peptide 1 receptor |
%Max (Mean) |
= |
-2.036 |
% |
GPCR beta-arrestin recruitment assay with target: GLP1R Assay Type: PRESTO-Tango Concentration: 0.00001 |
CHEMBL5209801 |
| Glucagon-like peptide 1 receptor |
%Inhib (Mean) |
= |
-42.03 |
% |
GPCR beta-arrestin recruitment assay with target: GLP1R Assay Type: PRESTO-Tango Concentration: 0.00001 |
CHEMBL5209801 |
| Type-1 angiotensin II receptor |
%Max (Mean) |
= |
-1.04 |
% |
GPCR beta-arrestin recruitment assay with target: AGTR1 Assay Type: PRESTO-Tango Concentration: 0.00001 |
CHEMBL5209801 |
| Type-1 angiotensin II receptor |
%Inhib (Mean) |
= |
-20.0 |
% |
GPCR beta-arrestin recruitment assay with target: AGTR1 Assay Type: PRESTO-Tango Concentration: 0.00001 |
CHEMBL5209801 |
